What 13 Analyst Ratings Have To Say About Moderna

What 13 Analyst Ratings Have To Say About Moderna

2 weeks from now

In the last 3 months, 13 analysts have offered 12-month price targets for Moderna. The company has an average price target of $182.85 with a high of $275.00 and a low of $93.00.

businessinsider.com

Moderna, Inc. (MRNA) Analyst Ratings - Stock Analysis

2 weeks from now

Jan 6, 2025  · A list of analyst ratings for Moderna (MRNA) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. ... +24.13%: Nov 4, 2024 : Eliana …

stockanalysis.com

Moderna (NASDAQ:MRNA) Stock, Analyst Ratings, Price Targets

2 weeks from now

Moderna Inc has a consensus price target of $94.14 based on the ratings of 27 analysts. The high is $208 issued by Chardan Capital on January 18, 2023 . The low is $40 issued by Wolfe …

benzinga.com

Moderna (MRNA) Stock Forecast & Price Target - TipRanks

2 weeks from now

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months. MRNA Stock 12 Month Forecast ... $61.56 (45.70% Upside) …

tipranks.com

What 10 Analyst Ratings Have To Say About Moderna

2 weeks from now

Jan 24, 2023  · These 10 analysts have an average price target of $187.4 versus the current price of Moderna at $194.19, implying downside. Below is a summary of how these 10 analysts …

businessinsider.com

Moderna's MRNA Technology Looks Undervalued Despite Lower …

2 weeks from now

2 days ago  · Moderna's massive covid vaccine sales and prepayments left it with $18.2 billion in cash at the end of 2022, but that balance is steadily shrinking due to previous share …

morningstar.com

10 Analysts Have This To Say About Moderna | Markets Insider

2 weeks from now

Apr 10, 2023  · These 10 analysts have an average price target of $163.0 versus the current price of Moderna at $159.68, implying upside. Below is a summary of how these 10 analysts rated …

businessinsider.com

Moderna Surprises The Street By Predicting A Bigger-than …

2 weeks from now

2 days ago  · Moderna said it expects 2025 revenue to range between $1.5 billion and $2.5 billion after hitting as much as $3.1 billion last year. Analysts expect, on average, $2.92 billion in …

apnews.com

Moderna: 2025 Contrarian Play (NASDAQ:MRNA) - Seeking Alpha

2 weeks from now

Dec 31, 2024  · Bernstein analyst Courtney Breen maintained a Hold rating on Moderna (MRNA – Research Report) yesterday and set a price target of $55.00. The company’s shares closed …

seekingalpha.com

Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?

2 weeks from now

1 day ago  · Moderna Stock's Bearish Ratings. Moderna stock is showing bearish fundamentals and technicals. ... analysts say. In the meantime, its ... 1/13/2025 Moderna stock crashed …

investors.com

Moderna Stock Jumps 12%: Sell The News Or Buy The Future?

2 weeks from now

Jan 7, 2025  · The analyst forecasts on MarketBeat have a consensus price target of $79.50 on MRNA stock. That gives the stock nearly 77% upside from the closing price on January 7. …

marketbeat.com

Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?

2 weeks from now

1 day ago  · This means Moderna stock ranks in the bottom 4% of all stocks when it comes to 12-month performance. Moderna shares also have a low Composite Rating of 19, putting them in …

inkl.com

13 Analysts Have This To Say About Intellia Therapeutics

2 weeks from now

2 days ago  · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $51.92, a high estimate of $91.00, and a low estimate …

nasdaq.com

4 Analysts Have This To Say About Moderna | Markets Insider

2 weeks from now

Sep 8, 2022  · According to 4 analyst offering 12-month price targets in the last 3 months, Moderna has an average price target of $128.25 with a high of $197.00 and a low of $74.00.

businessinsider.com